PhRMA (@PhRMA) / X

PhRMA

16.9K posts

PhRMA

@PhRMA

Representing America’s biopharma & biotech companies. Shaping policy so science thrives & patients benefit.

Washington, DC

Joined February 2010

Affiliates Replies Media

Pinned
PhRMA
@PhRMA
Jun 15
When your child is sick, time is everything. ⏳ Americans get new medicines 3 years faster than other countries. But if Washington copies other countries’ price control policies, we could be forced to wait, too. Our new ad highlights what's at stake. Watch now:
00:00
New “America Cures” ad highlights that U.S. patients get new medicines
From phrma.org
PhRMA
@PhRMA
4h
“The last thing I want to see is someone in the ER because of an adverse reaction to a drug that hasn’t been reviewed by the FDA, especially when there is an FDA-approved option.” Dr. Mike breaks down 3 things you should know about compounded drugs.
00:00
PhRMA
@PhRMA
8h
Made up terms like "patent thickets" and "evergreening," share one thing: none of them hold up to scrutiny. The evidence has debunked each one. But because they continue to come up, it’s time to correct the record. Read more:
Setting the record straight: 3 facts about drug patents
From phrma.org
PhRMA
@PhRMA
Jul 15
Fortunately, policymakers in both parties have started cracking down on abusive practices from PBMs. But making medicine more affordable requires building on these efforts with additional reforms. Check out @robzirk’s new op-ed in @thehill on how the work continues ⬇️
Robert Zirkelbach
@robzirk
Jul 15
Today, I shared my thoughts in @thehill: Our health care system is dominated by a handful of vertically integrated conglomerates that can block patients' access to more affordable medicine options to boost their own profits. Read my full op-ed: thehill.com/opinion/health…
PhRMA
@PhRMA
Jul 15
Global competition for biopharmaceutical innovation is accelerating. On @decidersshow, hosts @BrodyMullinsDC and @camoosomiller spoke with our CEO @steveubl about why the U.S. must continue to strengthen research, investment and clinical development to maintain its leadership.
00:00
PhRMA
@PhRMA
Jul 14
Some of today's medical breakthroughs would have seemed unimaginable just a generation ago. On @decidersshow, PhRMA President and CEO @steveubl joined @BrodyMullinsDC and @camoosomiller to discuss how medical innovation is transforming lives and why policies that support
PhRMA
@PhRMA
Jul 13
Patients want affordable care and timely access to the medicines their doctors prescribe. Our latest guest blog from Lauren Bumgardner Current, a Voters for Cures patient advocate from North Carolina, explains why price controls won’t solve the challenges she faces to get her
Guest Blog: Price controls won’t lower costs when insurers control access
From phrma.org
PhRMA
@PhRMA
Jul 8
Compounded drugs aren’t FDA-approved—and the rise of mass-produced “personalized” knockoffs should concern everyone. Aggressive marketing downplays real risks. The FDA and policymakers must continue to act to stop bad actors who bypass approvals and put patient safety at risk.
PhRMA
@PhRMA
Jul 6
Life-changing treatments are available in the United States three years faster than in other high-income countries. But harmful policies like price setting could put our leadership at risk. Tell Washington, keep America in the lead.
00:00
PhRMA
@PhRMA
Jul 5
Biopharma investments create jobs and drive breakthroughs across America. From Texas to Florida to Maryland, Illinois and Colorado, the biopharmaceutical industry supports thousands of jobs and advances innovation. When biopharma grows, communities benefit.
00:00
PhRMA
@PhRMA
Jul 4
For 250 years, America has championed innovation. 🇺🇸 By protecting invention and rewarding risk, our nation built an innovation ecosystem that continues to drive breakthroughs for patients and strengthen American leadership. The result? An innovation ecosystem that is the
00:00
PhRMA
@PhRMA
Jul 3
U.S. biopharma didn't lead the world for 40 years by luck. It’s thanks to smart policy: -Orphan Drug Act: 38 → 750+ rare disease therapies -Hatch-Waxman: 90% generic Rxs -Bayh-Dole: 200+ new medicines Happy 250th, America. 🇺🇸
Smart Policy Built U.S. Biopharma Innovation
From innovation.org
PhRMA
@PhRMA
Jul 2
How did America become the world's leading engine for medical innovation? In a new op-ed with @RealClearHealth, our CEO @steveubl explores how 250 years of smart policy choices helped build America's biopharmaceutical edge—and why protecting that foundation matters for the next
How 250 years of smart policy built America's biopharmaceutical edge
From phrma.org
PhRMA
@PhRMA
Jul 2
When biopharma invests in America, communities grow. Industry investment creates jobs, strengthens local economies and delivers benefits that reach far beyond biopharma.
00:00